Literature DB >> 697352

Erythropoietin concentration in amphotericin B-induced anemia.

R R MacGregor, J E Bennett, A J Erslev.   

Abstract

Amphotericin B was given to six patients with systemic fungal infections. A dose averaging 1.78 g, administered from 42 to 144 days, was associated with a fall in hematocrit to a mean value of 25.8%. Despite this degree of anemia, no elevation of erythropoietin concentrations in urine or serum could be detected. Thus, amphotericin appears to cause anemia by inhibiting erythropoietin production rather than by suppressing bone marrow activity directly.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 697352      PMCID： PMC352445          DOI： 10.1128/AAC.14.2.270

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS.

Authors:  W T BUTLER; J E BENNETT; D W ALLING; P T WERTLAKE; J P UTZ; G J HILL
Journal:  Ann Intern Med       Date:  1964-08       Impact factor: 25.391

2.  ANEMIA INDUCED BY AMPHOTERICIN B.

Authors:  M W BRANDRISS; S M WOLFF; R MOORES; F STOHLMAN
Journal:  JAMA       Date:  1964-08-31       Impact factor: 56.272

Review 3.  Chemotherapy of systemic mycoses (first of two parts).

Authors:  J E Bennett
Journal:  N Engl J Med       Date:  1974-01-03       Impact factor: 91.245

Review 4.  The anaemia of chronic disorders.

Authors:  G E Cartwright; G R Lee
Journal:  Br J Haematol       Date:  1971-08       Impact factor: 6.998

5.  Amphotericin B toxicity. A follow-up report of 53 patients.

Authors:  R P Miller; J H Bates
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

6.  The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation.

Authors:  J W Adamson
Journal:  Blood       Date:  1968-10       Impact factor: 22.113

7.  The anemia of chronic disorders: studies of marrow regulation and iron metabolism.

Authors:  S W Douglas; J W Adamson
Journal:  Blood       Date:  1975-01       Impact factor: 22.113

8.  Bone marrow erythropoiesis in the anemia of infection, inflammation, and malignancy.

Authors:  S Zucker; S Friedman; R M Lysik
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

9.  The toxic effects of amphotericin B in man.

Authors:  C W HOLEMAN; H EINSTEIN
Journal:  Calif Med       Date:  1963-08
  9 in total
  7 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro.

Authors:  T C Meeker; M S Siegel; F M Shiota; J J Crowley; R W McGuffin
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.

Authors:  Jigar V Desai; Amanda Urban; Michail S Lionakis; Alexandra F Freeman; Doris Z Swaim; Benjamin Colton; Lilian W Kibathi; Elise M N Ferrè; Pamela Stratton; Melissa A Merideth; Sally Hunsberger; Theresa Matkovits; Raphael Mannino; Steven M Holland; Edmund Tramont
Journal:  Antimicrob Agents Chemother       Date:  2022-06-14       Impact factor: 5.938

5.  Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.

Authors:  L Tugume; B M Morawski; M Abassi; N C Bahr; R Kiggundu; H W Nabeta; K H Hullsiek; K Taseera; A K Musubire; C Schutz; C Muzoora; D A Williams; M A Rolfes; G Meintjes; J Rhein; D B Meya; D R Boulware
Journal:  HIV Med       Date:  2016-04-28       Impact factor: 3.180

Review 6.  Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Authors:  C A Lyman; T J Walsh
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 7.  David and Goliath: chemical perturbation of eukaryotes by bacteria.

Authors:  Louis K Ho; Justin R Nodwell
Journal:  J Ind Microbiol Biotechnol       Date:  2015-10-03       Impact factor: 3.346
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.